These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26787685)

  • 1. Predictive Value for Galectin 3 and Cardiotrophin 1 in Hemodialysis Patients.
    Hogas S; Schiller A; Voroneanu L; Constantinescu D; Timar R; Cianga P; Siriopol D; Bob F; Cianga C; Onofriescu M; Gadalean F; Hogas M; Mihaescu A; Bilha SC; Timar B; Kanbay M; Banach M; Covic A
    Angiology; 2016 Oct; 67(9):854-9. PubMed ID: 26787685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Galectin-3 levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study.
    Liu S; Wu Q; Zhang S; Wang Z; Liu H; Teng L; Xiao P; Lu Y; Wang X; Dong C; Xiao J; Zhang J
    BMC Nephrol; 2022 Jan; 23(1):5. PubMed ID: 34979958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of cardiac troponin T and I in hemodialysis patients.
    Kalaji FR; Albitar S
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):939-45. PubMed ID: 22982904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Validation of a Screening Biomarker Approach Combining Amino-Terminal Pro-Brain Natriuretic Peptide With Galectin-3 Predicts Death and Cardiovascular Events in Asymptomatic Hemodialysis Patients.
    Voroneanu L; Siriopol D; Apetrii M; Hogas S; Onofriescu M; Nistor I; Kanbay M; Dumea R; Cusai S; Cianga P; Constantinescu D; Covic A
    Angiology; 2018 May; 69(5):449-455. PubMed ID: 28974104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin and mortality in hemodialysis patients with cardiovascular disease.
    Winther S; Christensen JH; Flyvbjerg A; Schmidt EB; Jørgensen KA; Skou-Jørgensen H; Svensson M
    Clin Nephrol; 2013 Sep; 80(3):161-7. PubMed ID: 23547804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can be galectin-3 a novel marker in determining mortality in hemodialysis patients?
    Ozkan G; Ulusoy S; Menteşe A; Guvercin B; Karahan SC; Yavuz A; Altay DU; Ocal M
    Clin Biochem; 2015 Aug; 48(12):768-73. PubMed ID: 25977067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of high serum bicarbonate levels on mortality in hemodialysis patients.
    Chang KY; Kim HW; Kim WJ; Kim YK; Kim SH; Song HC; Kim YO; Jin DC; Choi EJ; Yang CW; Kim YL; Kim NH; Kang SW; Kim YS; Kim YS
    Korean J Intern Med; 2017 Jan; 32(1):109-116. PubMed ID: 27044857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
    Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
    Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis.
    Tanaka M; Ishii H; Aoyama T; Takahashi H; Toriyama T; Kasuga H; Takeshita K; Yoshikawa D; Amano T; Murohara T
    Atherosclerosis; 2011 Dec; 219(2):643-7. PubMed ID: 22018643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum β-trace protein and risk of mortality in incident hemodialysis patients.
    Shafi T; Parekh RS; Jaar BG; Plantinga LC; Oberai PC; Eckfeldt JH; Levey AS; Powe NR; Coresh J
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1435-45. PubMed ID: 22745274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease.
    Maiolino G; Rossitto G; Pedon L; Cesari M; Frigo AC; Azzolini M; Plebani M; Rossi GP
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):725-32. PubMed ID: 25614283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
    Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
    Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of blood flow rate during hemodialysis on all-cause mortality.
    Chang KY; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
    Korean J Intern Med; 2016 Nov; 31(6):1131-1139. PubMed ID: 26898596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malnutrition Inflammation Score cut-off predicting mortality in maintenance hemodialysis patients.
    Borges MC; Vogt BP; Martin LC; Caramori JC
    Clin Nutr ESPEN; 2017 Feb; 17():63-67. PubMed ID: 28361749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of high-flux dialysis on mortality rates in incident and prevalent hemodialysis patients.
    Kim HW; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
    Korean J Intern Med; 2014 Nov; 29(6):774-84. PubMed ID: 25378976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients.
    Yamada S; Ishii H; Takahashi H; Aoyama T; Morita Y; Kasuga H; Kimura K; Ito Y; Takahashi R; Toriyama T; Yasuda Y; Hayashi M; Kamiya H; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1793-8. PubMed ID: 20595691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral fat level is an independent risk factor for cardiovascular mortality in hemodialysis patients.
    Okamoto T; Morimoto S; Ikenoue T; Furumatsu Y; Ichihara A
    Am J Nephrol; 2014; 39(2):122-9. PubMed ID: 24503580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.